These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29514131)

  • 1. Potential of resveratrol in mitigating metabolic disturbances induced by ethanol.
    Szkudelski T; Szkudelska K
    Biomed Pharmacother; 2018 May; 101():579-584. PubMed ID: 29514131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol alleviates ethanol-induced hormonal and metabolic disturbances in the rat.
    Szkudelska K; Deniziak M; Roś P; Gwóźdź K; Szkudelski T
    Physiol Res; 2017 Mar; 66(1):135-145. PubMed ID: 27782737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and liver disease: from bench to bedside and community.
    Bishayee A; Darvesh AS; Politis T; McGory R
    Liver Int; 2010 Sep; 30(8):1103-14. PubMed ID: 20557453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat.
    Rivera H; Shibayama M; Tsutsumi V; Perez-Alvarez V; Muriel P
    J Appl Toxicol; 2008 Mar; 28(2):147-55. PubMed ID: 17541932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
    Gómez-Zorita S; Fernández-Quintela A; Macarulla MT; Aguirre L; Hijona E; Bujanda L; Milagro F; Martínez JA; Portillo MP
    Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and diabetes: from animal to human studies.
    Szkudelski T; Szkudelska K
    Biochim Biophys Acta; 2015 Jun; 1852(6):1145-54. PubMed ID: 25445538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats.
    Hamadi N; Mansour A; Hassan MH; Khalifi-Touhami F; Badary O
    J Biochem Mol Toxicol; 2012 Oct; 26(10):384-92. PubMed ID: 22791351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-resveratrol alone and hydroxystilbenes of rhubarb (Rheum rhaponticum L.) root reduce liver damage induced by chronic ethanol administration: a comparative study in mice.
    Raal A; Pokk P; Arend A; Aunapuu M; Jõgi J; Okva K; Püssa T
    Phytother Res; 2009 Apr; 23(4):525-32. PubMed ID: 19067386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
    Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
    Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and antifibrotic effects of resveratrol in the lung.
    Conte E; Fagone E; Fruciano M; Gili E; Iemmolo M; Vancheri C
    Histol Histopathol; 2015 May; 30(5):523-9. PubMed ID: 25515609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of resveratrol and other polyphenols in hepatic steatosis.
    Aguirre L; Portillo MP; Hijona E; Bujanda L
    World J Gastroenterol; 2014 Jun; 20(23):7366-80. PubMed ID: 24966607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
    Rivera L; Morón R; Zarzuelo A; Galisteo M
    Biochem Pharmacol; 2009 Mar; 77(6):1053-63. PubMed ID: 19100718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet.
    Ahn J; Cho I; Kim S; Kwon D; Ha T
    J Hepatol; 2008 Dec; 49(6):1019-28. PubMed ID: 18930334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of resveratrol on alcohol-induced mortality and liver lesions in mice.
    Bujanda L; García-Barcina M; Gutiérrez-de Juan V; Bidaurrazaga J; de Luco MF; Gutiérrez-Stampa M; Larzabal M; Hijona E; Sarasqueta C; Echenique-Elizondo M; Arenas JI
    BMC Gastroenterol; 2006 Nov; 6():35. PubMed ID: 17105669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis.
    Hussein MA
    J Med Food; 2013 Mar; 16(3):246-54. PubMed ID: 23305807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effect of resveratrol on atherogenic diet-fed rats.
    Meng C; Liu JL; Du AL
    Int J Clin Exp Pathol; 2014; 7(11):7899-906. PubMed ID: 25550830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver.
    Kasdallah-Grissa A; Mornagui B; Aouani E; Hammami M; El May M; Gharbi N; Kamoun A; El-Fazaâ S
    Life Sci; 2007 Feb; 80(11):1033-9. PubMed ID: 17258234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
    Akar F; Pektas MB; Tufan C; Soylemez S; Sepici A; Ulus AT; Gokalp B; Ozturk K; Surucu HS
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):119-31. PubMed ID: 20676927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekend ethanol consumption and high-sucrose diet: resveratrol effects on energy expenditure, substrate oxidation, lipid profile, oxidative stress and hepatic energy metabolism.
    Rocha KK; Souza GA; Seiva FR; Ebaid GX; Novelli EL
    Alcohol Alcohol; 2011; 46(1):10-6. PubMed ID: 21139018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.